Keon-Wook Kang - Search Results

Year	Number of Results
2002	9
2003	6
2004	3
2005	13
2006	16
2007	11
2008	21
2009	27
2010	33
2011	33
2012	29
2013	22
2014	32
2015	31
2016	26
2017	26
2018	20
2019	34
2020	20
2021	17
2022	23
2023	22
2024	5

1

HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.

Choi JM, Oh SJ, Lee SY, Im JH, Oh JM, Ryu CS, Kwak HC, Lee JY, Kang KW, Kim SK. Choi JM, et al. Among authors: kang kw. Arch Pharm Res. 2015;38(5):691-704. doi: 10.1007/s12272-014-0502-6. Epub 2014 Oct 22. Arch Pharm Res. 2015. PMID: 25336106

2

Imaging in Tumor Immunology.

Kim EE, Youn H, Kang KW. Kim EE, et al. Among authors: kang kw. Nucl Med Mol Imaging. 2021 Oct;55(5):225-236. doi: 10.1007/s13139-021-00706-6. Epub 2021 Jul 27. Nucl Med Mol Imaging. 2021. PMID: 34721715 Free PMC article. Review.

3

Therapeutic application of GPR119 ligands in metabolic disorders.

Yang JW, Kim HS, Choi YW, Kim YM, Kang KW. Yang JW, et al. Among authors: kang kw. Diabetes Obes Metab. 2018 Feb;20(2):257-269. doi: 10.1111/dom.13062. Epub 2017 Aug 22. Diabetes Obes Metab. 2018. PMID: 28722242 Review.

4

Phosphatidylserine receptor-targeting therapies for the treatment of cancer.

Park M, Kang KW. Park M, et al. Among authors: kang kw. Arch Pharm Res. 2019 Jul;42(7):617-628. doi: 10.1007/s12272-019-01167-4. Epub 2019 Jun 6. Arch Pharm Res. 2019. PMID: 31172440 Review.

5

Lactate as a major epigenetic carbon source for histone acetylation via nuclear LDH metabolism.

An YJ, Jo S, Kim JM, Kim HS, Kim HY, Jeon SM, Han D, Yook JI, Kang KW, Park S. An YJ, et al. Among authors: kang kw. Exp Mol Med. 2023 Oct;55(10):2238-2247. doi: 10.1038/s12276-023-01095-w. Epub 2023 Oct 2. Exp Mol Med. 2023. PMID: 37779146 Free PMC article.

6

The role and application of transcriptional repressors in cancer treatment.

Park M, Kang KW, Kim JW. Park M, et al. Among authors: kang kw. Arch Pharm Res. 2023 Jan;46(1):1-17. doi: 10.1007/s12272-023-01427-4. Epub 2023 Jan 16. Arch Pharm Res. 2023. PMID: 36645575 Review.

7

Multi-atlas cardiac PET segmentation.

Kim SJW, Seo S, Kim HS, Kim DY, Kang KW, Min JJ, Lee JS. Kim SJW, et al. Among authors: kang kw. Phys Med. 2019 Feb;58:32-39. doi: 10.1016/j.ejmp.2019.01.003. Epub 2019 Jan 18. Phys Med. 2019. PMID: 30824147

8

TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment.

Park M, Kuen DS, Park J, Choi M, Kim Y, Roh EC, Choi YJ, Kim YG, Chung Y, Cho SY, Kang KW. Park M, et al. Among authors: kang kw. J Immunother Cancer. 2023 Jan;11(1):e006084. doi: 10.1136/jitc-2022-006084. J Immunother Cancer. 2023. PMID: 36693679 Free PMC article.

9

History and Organizations for Radiological Protection.

Kang KW. Kang KW. J Korean Med Sci. 2016 Feb;31 Suppl 1(Suppl 1):S4-5. doi: 10.3346/jkms.2016.31.S1.S4. Epub 2016 Jan 29. J Korean Med Sci. 2016. PMID: 26908987 Free PMC article. Review.

10

Benzbromarone Induces Targeted Degradation of HSP47 Protein and Improves Hypertrophic Scar Formation.

Park JG, Lim DC, Park JH, Park S, Mok J, Kang KW, Park J. Park JG, et al. Among authors: kang kw. J Invest Dermatol. 2024 Mar;144(3):633-644. doi: 10.1016/j.jid.2023.09.279. Epub 2023 Oct 13. J Invest Dermatol. 2024. PMID: 37838329 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

411 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Results by year